List of Tables
Table 1. Nanopharmaceuticals Market Trends
Table 2. Nanopharmaceuticals Market Drivers & Opportunity
Table 3. Nanopharmaceuticals Market Challenges
Table 4. Nanopharmaceuticals Market Restraints
Table 5. Global Nanopharmaceuticals Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Nanopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 7. Global Nanopharmaceuticals Sales Volume by Company (2020-2025) & (K MT)
Table 8. Global Nanopharmaceuticals Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Nanopharmaceuticals Price by Company (2020-2025) & (USD/MT)
Table 10. Key Manufacturers Nanopharmaceuticals Manufacturing Base and Headquarters
Table 11. Key Manufacturers Nanopharmaceuticals Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Nanopharmaceuticals
Table 13. Global Nanopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanopharmaceuticals as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Nanopharmaceuticals Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Nanopharmaceuticals Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Nanopharmaceuticals Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Nanopharmaceuticals Sales Market Share in Value by Type (2020-2025)
Table 20. Global Nanopharmaceuticals Sales Market Share in Value by Type (2026-2031)
Table 21. Global Nanopharmaceuticals Sales Volume by Type: 2020 VS 2024 VS 2031 (K MT)
Table 22. Global Nanopharmaceuticals Sales Volume by Type (2020-2025) & (K MT)
Table 23. Global Nanopharmaceuticals Sales Volume by Type (2026-2031) & (K MT)
Table 24. Global Nanopharmaceuticals Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Nanopharmaceuticals Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Nanopharmaceuticals Price by Type (2020-2025) & (USD/MT)
Table 27. Global Nanopharmaceuticals Price by Type (2026-2031) & (USD/MT)
Table 28. Global Nanopharmaceuticals Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Nanopharmaceuticals Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Nanopharmaceuticals Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Nanopharmaceuticals Sales Market Share in Value by Application (2020-2025)
Table 32. Global Nanopharmaceuticals Sales Market Share in Value by Application (2026-2031)
Table 33. Global Nanopharmaceuticals Sales Volume by Application: 2020 VS 2024 VS 2031 (K MT)
Table 34. Global Nanopharmaceuticals Sales Volume by Application (2020-2025) & (K MT)
Table 35. Global Nanopharmaceuticals Sales Volume by Application (2026-2031) & (K MT)
Table 36. Global Nanopharmaceuticals Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Nanopharmaceuticals Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Nanopharmaceuticals Price by Application (2020-2025) & (USD/MT)
Table 39. Global Nanopharmaceuticals Price by Application (2026-2031) & (USD/MT)
Table 40. Global Nanopharmaceuticals Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Nanopharmaceuticals Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Nanopharmaceuticals Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Nanopharmaceuticals Sales Value by Region (2020-2025) & (%)
Table 44. Global Nanopharmaceuticals Sales Value by Region (2026-2031) & (%)
Table 45. Global Nanopharmaceuticals Sales Volume by Region (K MT): 2020 VS 2024 VS 2031
Table 46. Global Nanopharmaceuticals Sales Volume by Region (2020-2025) & (K MT)
Table 47. Global Nanopharmaceuticals Sales Volume by Region (2026-2031) & (K MT)
Table 48. Global Nanopharmaceuticals Sales Volume by Region (2020-2025) & (%)
Table 49. Global Nanopharmaceuticals Sales Volume by Region (2026-2031) & (%)
Table 50. Global Nanopharmaceuticals Average Price by Region (2020-2025) & (USD/MT)
Table 51. Global Nanopharmaceuticals Average Price by Region (2026-2031) & (USD/MT)
Table 52. Key Countries/Regions Nanopharmaceuticals Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Nanopharmaceuticals Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Nanopharmaceuticals Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Nanopharmaceuticals Sales Volume, (2020-2025) & (K MT)
Table 56. Key Countries/Regions Nanopharmaceuticals Sales Volume, (2026-2031) & (K MT)
Table 57. Merck Company Information
Table 58. Merck Introduction and Business Overview
Table 59. Merck Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Merck Nanopharmaceuticals Product Offerings
Table 61. Merck Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Introduction and Business Overview
Table 64. Pfizer Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 65. Pfizer Nanopharmaceuticals Product Offerings
Table 66. Pfizer Recent Development
Table 67. Novartis Company Information
Table 68. Novartis Introduction and Business Overview
Table 69. Novartis Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. Novartis Nanopharmaceuticals Product Offerings
Table 71. Novartis Recent Development
Table 72. Abbott Company Information
Table 73. Abbott Introduction and Business Overview
Table 74. Abbott Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Abbott Nanopharmaceuticals Product Offerings
Table 76. Abbott Recent Development
Table 77. GlaxoSmithKline Company Information
Table 78. GlaxoSmithKline Introduction and Business Overview
Table 79. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. GlaxoSmithKline Nanopharmaceuticals Product Offerings
Table 81. GlaxoSmithKline Recent Development
Table 82. Roche Company Information
Table 83. Roche Introduction and Business Overview
Table 84. Roche Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Roche Nanopharmaceuticals Product Offerings
Table 86. Roche Recent Development
Table 87. Sanofi Company Information
Table 88. Sanofi Introduction and Business Overview
Table 89. Sanofi Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Sanofi Nanopharmaceuticals Product Offerings
Table 91. Sanofi Recent Development
Table 92. Eli Lilly Company Information
Table 93. Eli Lilly Introduction and Business Overview
Table 94. Eli Lilly Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Eli Lilly Nanopharmaceuticals Product Offerings
Table 96. Eli Lilly Recent Development
Table 97. Astrazeneca Company Information
Table 98. Astrazeneca Introduction and Business Overview
Table 99. Astrazeneca Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Astrazeneca Nanopharmaceuticals Product Offerings
Table 101. Astrazeneca Recent Development
Table 102. Johnson & Johnson Company Information
Table 103. Johnson & Johnson Introduction and Business Overview
Table 104. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Johnson & Johnson Nanopharmaceuticals Product Offerings
Table 106. Johnson & Johnson Recent Development
Table 107. Celgene Company Information
Table 108. Celgene Introduction and Business Overview
Table 109. Celgene Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Celgene Nanopharmaceuticals Product Offerings
Table 111. Celgene Recent Development
Table 112. Novavax Company Information
Table 113. Novavax Introduction and Business Overview
Table 114. Novavax Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. Novavax Nanopharmaceuticals Product Offerings
Table 116. Novavax Recent Development
Table 117. Stryker Company Information
Table 118. Stryker Introduction and Business Overview
Table 119. Stryker Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Stryker Nanopharmaceuticals Product Offerings
Table 121. Stryker Recent Development
Table 122. Gilead Sciences Company Information
Table 123. Gilead Sciences Introduction and Business Overview
Table 124. Gilead Sciences Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 125. Gilead Sciences Nanopharmaceuticals Product Offerings
Table 126. Gilead Sciences Recent Development
Table 127. OSI Pharmaceuticals Company Information
Table 128. OSI Pharmaceuticals Introduction and Business Overview
Table 129. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 130. OSI Pharmaceuticals Nanopharmaceuticals Product Offerings
Table 131. OSI Pharmaceuticals Recent Development
Table 132. Kadmon Pharmaceuticals Company Information
Table 133. Kadmon Pharmaceuticals Introduction and Business Overview
Table 134. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 135. Kadmon Pharmaceuticals Nanopharmaceuticals Product Offerings
Table 136. Kadmon Pharmaceuticals Recent Development
Table 137. Samyang Biopharm Company Information
Table 138. Samyang Biopharm Introduction and Business Overview
Table 139. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 140. Samyang Biopharm Nanopharmaceuticals Product Offerings
Table 141. Samyang Biopharm Recent Development
Table 142. Mitsubishi Pharma Company Information
Table 143. Mitsubishi Pharma Introduction and Business Overview
Table 144. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 145. Mitsubishi Pharma Nanopharmaceuticals Product Offerings
Table 146. Mitsubishi Pharma Recent Development
Table 147. Kaken Pharmaceutical Company Information
Table 148. Kaken Pharmaceutical Introduction and Business Overview
Table 149. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 150. Kaken Pharmaceutical Nanopharmaceuticals Product Offerings
Table 151. Kaken Pharmaceutical Recent Development
Table 152. Selecta Biosciences Company Information
Table 153. Selecta Biosciences Introduction and Business Overview
Table 154. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 155. Selecta Biosciences Nanopharmaceuticals Product Offerings
Table 156. Selecta Biosciences Recent Development
Table 157. Par Pharmaceutical Company Information
Table 158. Par Pharmaceutical Introduction and Business Overview
Table 159. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 160. Par Pharmaceutical Nanopharmaceuticals Product Offerings
Table 161. Par Pharmaceutical Recent Development
Table 162. Cerulean Pharma Company Information
Table 163. Cerulean Pharma Introduction and Business Overview
Table 164. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 165. Cerulean Pharma Nanopharmaceuticals Product Offerings
Table 166. Cerulean Pharma Recent Development
Table 167. Navidea Biopharmaceuticals Company Information
Table 168. Navidea Biopharmaceuticals Introduction and Business Overview
Table 169. Navidea Biopharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 170. Navidea Biopharmaceuticals Nanopharmaceuticals Product Offerings
Table 171. Navidea Biopharmaceuticals Recent Development
Table 172. Lummy Company Information
Table 173. Lummy Introduction and Business Overview
Table 174. Lummy Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 175. Lummy Nanopharmaceuticals Product Offerings
Table 176. Lummy Recent Development
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Nanopharmaceuticals Downstream Customers
Table 180. Nanopharmaceuticals Distributors List
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Nanopharmaceuticals Product Picture
Figure 2. Global Nanopharmaceuticals Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Nanopharmaceuticals Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Nanopharmaceuticals Sales Volume (2020-2031) & (K MT)
Figure 5. Global Nanopharmaceuticals Sales Price (2020-2031) & (USD/MT)
Figure 6. Nanopharmaceuticals Report Years Considered
Figure 7. Global Nanopharmaceuticals Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Nanopharmaceuticals Players Sales Volume Ranking (2024) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nanopharmaceuticals Revenue in 2024
Figure 10. Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Liposomes Picture
Figure 12. Polymeric Micelles Picture
Figure 13. Solid Lipid Nanoparticles Picture
Figure 14. Microemulsion and Nnanoemulsion Picture
Figure 15. Nanosuspension Picture
Figure 16. Global Nanopharmaceuticals Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global Nanopharmaceuticals Sales Value Market Share by Type, 2024 & 2031
Figure 18. Global Nanopharmaceuticals Sales Volume by Type (2020 VS 2024 VS 2031) & (K MT)
Figure 19. Global Nanopharmaceuticals Sales Volume Market Share by Type, 2024 & 2031
Figure 20. Global Nanopharmaceuticals Price by Type (2020-2031) & (USD/MT)
Figure 21. Product Picture of Cancer and Tumor
Figure 22. Product Picture of Autoimmune Disorders
Figure 23. Product Picture of Inflammation
Figure 24. Product Picture of Others
Figure 25. Global Nanopharmaceuticals Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 26. Global Nanopharmaceuticals Sales Value Market Share by Application, 2024 & 2031
Figure 27. Global Nanopharmaceuticals Sales Volume by Application (2020 VS 2024 VS 2031) & (K MT)
Figure 28. Global Nanopharmaceuticals Sales Volume Market Share by Application, 2024 & 2031
Figure 29. Global Nanopharmaceuticals Price by Application (2020-2031) & (USD/MT)
Figure 30. North America Nanopharmaceuticals Sales Value (2020-2031) & (US$ Million)
Figure 31. North America Nanopharmaceuticals Sales Value by Country (%), 2024 VS 2031
Figure 32. Europe Nanopharmaceuticals Sales Value, (2020-2031) & (US$ Million)
Figure 33. Europe Nanopharmaceuticals Sales Value by Country (%), 2024 VS 2031
Figure 34. Asia Pacific Nanopharmaceuticals Sales Value, (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Nanopharmaceuticals Sales Value by Region (%), 2024 VS 2031
Figure 36. South America Nanopharmaceuticals Sales Value, (2020-2031) & (US$ Million)
Figure 37. South America Nanopharmaceuticals Sales Value by Country (%), 2024 VS 2031
Figure 38. Middle East & Africa Nanopharmaceuticals Sales Value, (2020-2031) & (US$ Million)
Figure 39. Middle East & Africa Nanopharmaceuticals Sales Value by Country (%), 2024 VS 2031
Figure 40. Key Countries/Regions Nanopharmaceuticals Sales Value (%), (2020-2031)
Figure 41. Key Countries/Regions Nanopharmaceuticals Sales Volume (%), (2020-2031)
Figure 42. United States Nanopharmaceuticals Sales Value, (2020-2031) & (US$ Million)
Figure 43. United States Nanopharmaceuticals Sales Value by Type (%), 2024 VS 2031
Figure 44. United States Nanopharmaceuticals Sales Value by Application (%), 2024 VS 2031
Figure 45. Europe Nanopharmaceuticals Sales Value, (2020-2031) & (US$ Million)
Figure 46. Europe Nanopharmaceuticals Sales Value by Type (%), 2024 VS 2031
Figure 47. Europe Nanopharmaceuticals Sales Value by Application (%), 2024 VS 2031
Figure 48. China Nanopharmaceuticals Sales Value, (2020-2031) & (US$ Million)
Figure 49. China Nanopharmaceuticals Sales Value by Type (%), 2024 VS 2031
Figure 50. China Nanopharmaceuticals Sales Value by Application (%), 2024 VS 2031
Figure 51. Japan Nanopharmaceuticals Sales Value, (2020-2031) & (US$ Million)
Figure 52. Japan Nanopharmaceuticals Sales Value by Type (%), 2024 VS 2031
Figure 53. Japan Nanopharmaceuticals Sales Value by Application (%), 2024 VS 2031
Figure 54. South Korea Nanopharmaceuticals Sales Value, (2020-2031) & (US$ Million)
Figure 55. South Korea Nanopharmaceuticals Sales Value by Type (%), 2024 VS 2031
Figure 56. South Korea Nanopharmaceuticals Sales Value by Application (%), 2024 VS 2031
Figure 57. Southeast Asia Nanopharmaceuticals Sales Value, (2020-2031) & (US$ Million)
Figure 58. Southeast Asia Nanopharmaceuticals Sales Value by Type (%), 2024 VS 2031
Figure 59. Southeast Asia Nanopharmaceuticals Sales Value by Application (%), 2024 VS 2031
Figure 60. India Nanopharmaceuticals Sales Value, (2020-2031) & (US$ Million)
Figure 61. India Nanopharmaceuticals Sales Value by Type (%), 2024 VS 2031
Figure 62. India Nanopharmaceuticals Sales Value by Application (%), 2024 VS 2031
Figure 63. Nanopharmaceuticals Industrial Chain
Figure 64. Nanopharmaceuticals Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
